Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients.
Saved in:
| Title: | Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients. |
|---|---|
| Authors: | Petricevic, Branka1 bpetricevic2001@yahoo.com, Laengle, Johannes1 johannes.laengle@gmx.at, Singer, Josef2,3 josef.singer@meduniwien.ac.at, Sachet, Monika1 monika.sachet@meduniwien.ac.at, Fazekas, Judit2,3 judit.fazekas@meduniwien.ac.at, Steger, Guenther2,3 guenther.steger@meduniwien.ac.at, Bartsch, Rupert4,5 rupert.bartsch@meduniwien.ac.at, Jensen-Jarolim, Erika2,3,5 erika.jensen-jarolim@meduniwien.ac.at, Bergmann, Michael1,5 michael.bergmann@meduniwien.ac.at |
| Source: | Journal of Translational Medicine. 2013, Vol. 11 Issue 1, p2-29. 28p. 1 Chart, 8 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
